EMAD ALSHAMI: Open Payments
NPI 1336168848 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$40,092 in 243 payments from 14 companies in 2025. Trend: 2023 $20,844 · 2024 $10,860 · 2025 $40,092
Speaker / faculty: $29,390Consulting: $5,500Food & beverage: $4,185Travel & lodging: $1,009Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 49 | $21,285 |
| ABBVIE INC. | 69 | $16,767 |
| E.R. Squibb & Sons, L.L.C. | 38 | $491 |
| Lundbeck LLC | 15 | $256 |
| Axsome Therapeutics, Inc. | 11 | $232 |
| Vanda Pharmaceuticals Inc. | 10 | $208 |
| Alkermes, Inc. | 16 | $185 |
| Otsuka America Pharmaceutical, Inc. | 11 | $183 |
| Teva Pharmaceuticals USA, Inc. | 10 | $178 |
| Janssen Pharmaceuticals, Inc | 7 | $148 |
Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, Auvelity, ARISTADA, AUSTEDO XR, HETLIOZ.
Industry payments across OH — which companies pay providers there.
